← Dashboard
Nov 05, 2026 11:53 AM ET
Signal
Corporate
Agios Pharmaceuticals GAAP EPS of -$1.09 beats by $0.15, revenue of $55.39M beats by $3.79M
Agios Pharmaceuticals beat EPS and revenue estimates.
What changed
Agios Pharmaceuticals beat EPS and revenue estimates.
Why it matters
Agios Pharmaceuticals beat EPS and revenue estimates. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →
FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →
$FMX →